NasdaqGS:AMGNBiotechs
Amgen’s Real Time FDA Trials Raise Questions On Pipeline Value
Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiative.
The program is designed to enable continuous clinical development with real time data sharing between companies and the FDA.
The collaboration focuses on reshaping how trials are designed, monitored, and adapted during the development of new therapies.
Amgen is a large biotechnology company with a broad portfolio of therapies and...